tetano
Editor, Senior Moderator
Mo Med. 2014 Jul-Aug;111(4):321-5.
Progress toward the development of universal influenza vaccines.
Hoft DF, Belshe RB.
Abstract
Influenza remains a major problem causing significant morbidity and mortality annually and periodic pandemics with the potential for 10-100 fold increased mortality. Conventional vaccines can be highly effective if generated each year to match currently circulating viruses. Ongoing research focuses on producing cross-protective vaccines that induce T cell and/ or antibody responses specific for highly conserved viral epitopes. The Saint Louis University Center for Vaccine Development (SLUCVD) is highly engaged in multiple efforts to generate universally relevant influenza vaccines.
PMID:
25211862
[PubMed - in process]
http://www.ncbi.nlm.nih.gov/pubmed/25211862
Progress toward the development of universal influenza vaccines.
Hoft DF, Belshe RB.
Abstract
Influenza remains a major problem causing significant morbidity and mortality annually and periodic pandemics with the potential for 10-100 fold increased mortality. Conventional vaccines can be highly effective if generated each year to match currently circulating viruses. Ongoing research focuses on producing cross-protective vaccines that induce T cell and/ or antibody responses specific for highly conserved viral epitopes. The Saint Louis University Center for Vaccine Development (SLUCVD) is highly engaged in multiple efforts to generate universally relevant influenza vaccines.
PMID:
25211862
[PubMed - in process]
http://www.ncbi.nlm.nih.gov/pubmed/25211862